Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TEAD proteins are a highly conserved family of transcription factors, characterized by a DNA-binding domain called the TEA domain and a protein-binding domain for transcriptional co-activator association (e.g., YAP and TAZ). Four homologous TEAD genes exist in mammals (TEAD1–4). These proteins require co-activators for transcriptional activity and regulate genes essential for development, stem cell fate, cell proliferation, apoptosis, and organ formation. TEAD proteins are core effectors of the Hippo signaling pathway, which is implicated in cancer progression, fibrosis, and cellular differentiation. TEAD activity is regulated by interaction with YAP/TAZ and other cofactors; inhibition of these interactions is being explored as a therapeutic strategy for cancer and other diseases. TEAD proteins are expressed widely in embryonic and some adult tissues, with specific isoforms showing tissue and developmental stage preference.
Drugs may inhibit YAP/TAZ-TEAD interaction, suppressing oncogenic transcription and cell proliferation. Modulation of transcriptional co-activator binding (YAP, TAZ, VGLL, p160 protein).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TEA domain family member protein (TEAD).